'''Ameltolide''', a 4-aminobenzamide [[derivative (chemistry)|derivative]], is an experimental [[anticonvulsant]] agent, effective at inhibiting [[seizures]] in [[animal model]]s.<ref>{{cite journal |doi=10.1021/jm00108a003 |title=Synthesis and pharmacological evaluation of a major metabolite of ameltolide, a potent anticonvulsant |year=1991 |last1=Robertson |first1=David W. |last2=Beedle |first2=E. E. |last3=Krushinski |first3=Joseph H. |last4=Lawson |first4=Ronald R. |last5=Parli |first5=C. John |last6=Potts |first6=Brian |last7=Leander |first7=J. David |journal=Journal of Medicinal Chemistry |volume=34 |issue=4 |pages=1253–7 |pmid=2016702}}</ref> It is non-toxic at dosing levels and no undesirable side effects are attributable to its application.<ref>{{cite journal |doi=10.1002/tera.1420440107 |title=Ameltolide. I: Developmental toxicology studies of a novel anticonvulsant |year=1991 |last1=Higdon |first1=Gary L. |last2=McKinley |first2=Edmund R. |last3=Markham |first3=Janet K. |journal=Teratology |volume=44 |pages=37–44 |pmid=1957261 |issue=1}}</ref>
